Literature DB >> 32451607

Removal of foveal hard exudates by subretinal balanced salt solution injection using 38-gauge needle in diabetic patients.

Kazuyuki Kumagai1, Nobuchika Ogino2, Marie Fukami3, Mariko Furukawa3.   

Abstract

PURPOSE: To examine the anatomic and visual outcomes after removal of foveal hard exudates through a macular hole created by subretinal balanced salt solution (BSS) injection.
METHODS: This was a retrospective, consecutive, case series. Six patients (7 eyes) underwent vitrectomy with removal of foveal hard exudates. All patients were women and the mean age was 65 years (range from 55 to 71). All patients had a history of panretinal photocoagulation. Previous treatments included intravitreal anti-vascular endothelial growth factor injection in one eye and vitrectomy in both eyes of one patient. The geometric mean preoperative decimal visual acuity was 0.11 (range from 0.08 to 0.3). The mean postoperative follow-up period was 12 months (range from 6 to 19). The status of lens was two phakic and five pseudophakic. Surgical procedures included simultaneous cataract surgery if phakic, creation of posterior vitreous detachment if not present, internal limiting membrane (ILM) peeling and a gas or air tamponade. Manual subretinal BSS injection using 38-gauge needle was performed at ILM-peeled area. Removal of foveal hard exudates was conducted by the water flow through the macular hole created during subretinal BSS injection.
RESULTS: Foveal hard exudates decreased in all cases early after surgery. The geometric mean final decimal visual acuity was 0.31 (range from 0.1 to 0.9). Visual acuity improved more than 0.2 LogMAR units in six eyes and unchanged in one eye. There was no severe complication and recurrence of macular edema.
CONCLUSION: This procedure may be effective for foveal hard exudates in diabetic patients.

Entities:  

Keywords:  38G cannula; Diabetic macular edema; Diabetic retinopathy; Foveal hard exudates; Vitrectomy

Mesh:

Substances:

Year:  2020        PMID: 32451607     DOI: 10.1007/s00417-020-04756-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  15 in total

1.  Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.

Authors:  Eugene Yu-Chuan Kang; Tien-Hsing Chen; Sunir J Garg; Chi-Chin Sun; Je-Ho Kang; Wei-Chi Wu; Ming-Jui Hung; Chi-Chun Lai; Wen-Jin Cherng; Yih-Shiou Hwang
Journal:  JAMA Ophthalmol       Date:  2019-04-01       Impact factor: 7.389

2.  Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trial.

Authors:  Jörgen Larsson; Annette Kifley; Meidong Zhu; Jie Jin Wang; Paul Mitchell; Florian K P Sutter; Mark C Gillies
Journal:  Acta Ophthalmol       Date:  2008-09-10       Impact factor: 3.761

3.  [Subthreshold micropulse diode laser photocoagulation for diabetic macular edema with hard exudates].

Authors:  Yosuke Nakamura; Tomoaki Tatsumi; Miyuki Arai; Yoko Takatsuna; Yoshinori Mitamura; Shuichi Yamamoto
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2009-08

4.  Distribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photography.

Authors:  Berthold Pemp; Gábor Deák; Sonja Prager; Christoph Mitsch; Jan Lammer; Gerald Schmidinger; Christoph Scholda; Ursula Schmidt-Erfurth; Matthias Bolz
Journal:  Retina       Date:  2014-12       Impact factor: 4.256

5.  [Surgical removal of subfoveal hard exudates in diabetic maculopathy].

Authors:  Kazuyuki Kumagai; Nobuchika Ogino; Mariko Furukawa; Seiji Demizu; Kazunari Atsumi; Hideyuki Kurihara; Masayoshi Iwaki; Hitoshi Ishigooka; Naoko Tachi
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2002-09

6.  Visual improvement after removal of submacular exudates in patients with diabetic maculopathy.

Authors:  T Sakuraba; Y Suzuki; H Mizutani; M Nakazawa
Journal:  Ophthalmic Surg Lasers       Date:  2000 Jul-Aug

7.  Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.

Authors:  Amitha Domalpally; Michael S Ip; Jason S Ehrlich
Journal:  Ophthalmology       Date:  2015-01-17       Impact factor: 12.079

8.  Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography.

Authors:  Gábor Gy Deák; Matthias Bolz; Katharina Kriechbaum; Sonja Prager; Georgios Mylonas; Christoph Scholda; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2010-01-15       Impact factor: 12.079

9.  Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.

Authors:  Amod Gupta; Vishali Gupta; Shveta Thapar; Anil Bhansali
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

10.  Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates.

Authors:  Sohee Jeon; Won Ki Lee
Journal:  Clin Ophthalmol       Date:  2014-08-12
View more
  2 in total

1.  Removal of Subfoveal Massive Hard Exudates through an Intentional Macular Hole in Patients with Diabetic Maculopathy: A Report of Three Cases.

Authors:  Yukako Iwane; Hisanori Imai; Hiroko Yamada; Yasuyuki Sotani; Mariko Oishi; Makoto Nakamura
Journal:  Case Rep Ophthalmol       Date:  2022-08-29

Review 2.  Subretinal Injection Techniques for Retinal Disease: A Review.

Authors:  Cristina Irigoyen; Asier Amenabar Alonso; Jorge Sanchez-Molina; María Rodríguez-Hidalgo; Araceli Lara-López; Javier Ruiz-Ederra
Journal:  J Clin Med       Date:  2022-08-12       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.